Skip to main content
SpringerLink
Log in
Book cover

Praxis der Dialyse pp 101–117Cite as

Antikoagulation

  • Chapter
  • First Online:

Zusammenfassung

Das Ziel der Antikoagulation ist die Vermeidung von Thrombenbildung im extrakorporalen Kreislauf ohne eine unerwünschte Blutungsneigung auszulösen. Zum Einsatz kommen bei der chronischen Dialysebehandlung am häufigsten die in Tab. 4.1 aufgeführten Antikoagulanzien.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Bates SM, Weitz JI (2006) The status of new anticoagulants. Br J Haematol 134(1):3–19

    Article  CAS  PubMed  Google Scholar 

  • Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK (2006) Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 69(11):2087–2093

    Article  CAS  PubMed  Google Scholar 

  • Collignon F, Frydman A, Caplain H, Ozoux ML, Le Roux Y, Bouthier J, Thébault JJ (1995) Comparison of the pharmacokinetic profiles of three low molecular mass heparins-dalteparin, enoxaparin and nadroparin-administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism). Thromb Haemost. 73(4):630–640

    CAS  PubMed  Google Scholar 

  • Eichler P, Friesen HJ, Lubenow N, Jaeger B, Greinacher A (2000) Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance. Blood 96(7):2373–2378

    CAS  PubMed  Google Scholar 

  • Gordon LA, Perkins HA, Richards V et al. (1956) Studies in regional heparinization. II. Artificial-kidney hemodialysis without systemic heparinization; preliminary report of a method using simultaneous infusion of heparin and protamine. N Engl J Med; 255:1063

    Article  CAS  PubMed  Google Scholar 

  • Greinacher A, Lubenow N (2003) Heparin-Induced Thrombocytopenia. Orphanet Encyclopedia. December

    Google Scholar 

  • Hammerstingl C, Omran H Nickenig G (2009) Peri-operatives Bridging einer oralen Antikoagulation bei Patienten mit chronischer Niereninsuffizienz, Journal für Kardiologie 2009; 16 (7–8), 290–294

    Google Scholar 

  • Hetzel GR, Sucker C (2005) The heparins: all a nephrologist should know, Nephrol Dial Transplant 20: 2036–2042

    Article  PubMed  Google Scholar 

  • Hemodialyzer Membranes (2007) Implications for Clinical Use. Clin J Am Soc Nephrol 2: 470–476

    Article  Google Scholar 

  • Hirsh J, Raschke R (2004) Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126(3 Suppl):188S–203S

    Google Scholar 

  • Hirsh J, Anand SS, Halperin JL, Fuster V (2001) Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. Circulation; 103:2994

    Article  CAS  PubMed  Google Scholar 

  • Janssen MJ, Deegens JK, Kapinga TH, Beukhof JR, Huijgens PC, van Loenen AC, van der Meulen J (1996) Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients. Kidney Int 49(3):806–813

    Article  CAS  PubMed  Google Scholar 

  • Kiser TH, Fish DN (2006) Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction. Pharmacotherapy, 26(4):452–460

    Article  CAS  PubMed  Google Scholar 

  • Lewis BE, Wallis DE, Berkowitz SD et al. (2001) Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 103: 1838–1843

    Article  CAS  PubMed  Google Scholar 

  • Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A (2006) Evaluation of pretest clinical score (4 T‘s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thrombosis and Haemostasis 4: 759–765

    CAS  Google Scholar 

  • Mahnel R, Bassus S, Kirchmaier CM (2009) Blutungskomplikationen unter Antikoagulanzien-Therapie, Internist, 50:1369–1380

    Article  CAS  PubMed  Google Scholar 

  • Martel N, Lee J, Wells PS (2005) Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 106(8):2710–5. Epub 2005 Jun 28

    Google Scholar 

  • Mureebe L, Coats RD, Silliman WR, Shuster TA, Nichols WK, Silver D (2004) Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients. Surgery, 136: 848–853

    Article  PubMed  Google Scholar 

  • Nadel S, Goldstein B et al. (2007) Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet. 369(9564):836–843

    Article  CAS  PubMed  Google Scholar 

  • Nutescu EA, Shapiro NL, Chevalier A, Amin AN (2005) A pharmacologic overview of current and emerging anticoagulants. Cleve Clin J Med. 72 Suppl 1:S2–6

    Article  PubMed  Google Scholar 

  • Nutescu EA, Shapiro NL, Chevalier A (2008) New anticoagulant agents: direct thrombin inhibitors. Cardiol Clin. 26(2):169–87, v–vi

    Article  PubMed  Google Scholar 

  • O’Donnell MJ et al. (2007) Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin. Ann Intern Med; 146:184–187

    Article  PubMed  Google Scholar 

  • Ota K, Kawaguchi H, Takahashi K, Ito K (1983) A new prostacyclin analog – An anticoagulant applicable to hemodialysis. Trans Am Soc Artif Intern Organs, 29:419

    CAS  PubMed  Google Scholar 

  • Sagedal S, Hartmann A, Sundstrøm K, Bjørnsen S, Fauchald P, Brosstad F (1999) A single dose of dalteparin effectively prevents clotting during haemodialysis Nephrol. Dial. Transplant. 14: 1943–1947

    Article  CAS  PubMed  Google Scholar 

  • Swartz RD, Flamenbaum W, Dubrow A, Hall JC, Crow JW, Cato A (1988) Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complications. J Clin Pharmacol, 28(9):818–825

    Article  CAS  PubMed  Google Scholar 

  • Teien AN, Bjoornson J (1976) Heparin elimination in uraemic patients on Haemodialysis. Scand J Haematol. 17(1):29–35

    Article  CAS  PubMed  Google Scholar 

  • Uchino S, Bellomo R, Morimatsu H et al. (2007) Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med., 33(9):1563–1570

    Article  PubMed  Google Scholar 

  • Warren HS, Suffedini AF et al. (2002) Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med. 26;347(13):1027–1030

    Article  PubMed  Google Scholar 

  • Warkentin TE, Greinacher A, Koster A, Lincoff AM (2008) Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133:340S

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dialysezentrum Wieblingen, Praxis für Nieren- und Hochdruckerkrankungen, Heidelberg, Deutschland

    Dr. med. Steffen Geberth

  2. Dialysezentrum Lindau, Praxis für Nieren- und Hochdruckkrankheiten, Lindau, Deutschland

    Dr. med. Rainer Nowack

Authors
  1. Dr. med. Steffen Geberth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. med. Rainer Nowack
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steffen Geberth .

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Geberth, S., Nowack, R. (2014). Antikoagulation. In: Praxis der Dialyse. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41208-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-41208-0_4

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-41207-3

  • Online ISBN: 978-3-642-41208-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation